— Know what they know.
Not Investment Advice

SYBE OTC

SYBLEU Inc
1W: +0.0% 1M: +0.0% 3M: +0.0% YTD: +0.0% 1Y: +0.0%
$0.06
+0.00 (+0.00%)
 
OTC · Healthcare · Biotechnology · Tech Score Sell · Power 45 · $583742 mcap · 3M float · 0.098% daily turnover

Income Trends

Revenue
$12K -0.0% ▼
Gross Profit
$12K -0.0% ▼
Operating Income
-$149K -164.6% ▼
Net Income
-$180K +26.5% ▲
EPS (Diluted)
$-0.02 +24.2% ▲
EBITDA
-$142K -218.6% ▼

Profit Margins

Year-over-Year Growth

View Full Income Statement
Line ItemFY2019FY2020FY2021FY2022
Revenue$0$4K$12K$12K
YoY Growth+0.0%+0.0%+188.7%-0.0%
Cost of Revenue$0$0$0$0
Gross Profit$0$4K$12K$12K
Gross Margin—100.0%100.0%100.0%
R&D Expenses$39K$29K$5K$85K
SG&A Expenses$7K$63K$63K$75K
Operating Expenses$46K$92K$68K$161K
Operating Income-$46K-$88K-$56K-$149K
Operating Margin—-2178.0%-481.8%-1275.5%
Interest Expense$0$0$13K$14K
Income Before Tax-$46K-$80K-$245K-$180K
Tax Expense$0$21K$0$0
Net Income-$46K-$102K-$245K-$180K
Net Margin—-2513.5%-2097.0%-1541.6%
EPS (Diluted)$-0.01$-0.01$-0.02$-0.02
EBITDA$0-$88K$119K-$142K
Shares Outstanding9M11M11M10M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms